Back to search

Fatal hematologic toxicity with prolonged continuous administration of temozolomide (TMZ) during radiation therapy (RT) in the treatment of newly-diagnosed glioblastoma multiforme (GBM): Report of a Phase II trial

Data up to Jan 2025

Published2005
Citations20
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Fatal hematologic toxicity with prolonged continuous administration of temozolomide (TMZ)… (2005) – Journal of Clinical Oncology | Metascience Observatory Explorer